<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>MIMS Licence Changes and Product Updates RSS Feed</title>
<link>http://www.mims.co.uk/more/LicenceChanges/</link>
<lastBuildDate>Sun, 26 May 2013 01:34:24 GMT</lastBuildDate>
<language>en</language>
<copyright>Haymarket © 1957 – 2009</copyright>
<image>
<title>MIMS Licence Changes and Product Updates RSS Feed</title>
<link>http://www.mims.co.uk/more/LicenceChanges/</link>
<url>http://www.mims.co.uk/_images/aqua/mimsLogo.gif</url>
</image>
<item>
<guid>http://www.mims.co.uk/more/LicenceChanges/rss/article/1174984/Ixiaro-first-Japanese-encephalitis-vaccine-approved-paediatric-use-UK/</guid>
<title><![CDATA[Ixiaro: first Japanese encephalitis vaccine approved for paediatric use in the UK]]></title>
<link>http://www.mims.co.uk/more/LicenceChanges/rss/article/1174984/Ixiaro-first-Japanese-encephalitis-vaccine-approved-paediatric-use-UK/</link>
<pubDate>Tue, 02 Apr 2013 09:24:00 GMT</pubDate>
<description><![CDATA[Children aged 2 months and older can now receive the Japanese encephalitis vaccine, Ixiaro.]]></description>
</item>
<item>
<guid>http://www.mims.co.uk/more/LicenceChanges/rss/article/1174981/Onglyza-approved-triple-oral-therapy/</guid>
<title><![CDATA[Onglyza approved for triple oral therapy]]></title>
<link>http://www.mims.co.uk/more/LicenceChanges/rss/article/1174981/Onglyza-approved-triple-oral-therapy/</link>
<pubDate>Tue, 02 Apr 2013 09:22:00 GMT</pubDate>
<description><![CDATA[Onglyza (saxagliptin) can now be used in combination with metformin and a sulfonylurea in type II diabetes.]]></description>
</item>
<item>
<guid>http://www.mims.co.uk/more/LicenceChanges/rss/article/1174950/Isosorbide-mononitrate-shortage/</guid>
<title><![CDATA[Isosorbide mononitrate shortage]]></title>
<link>http://www.mims.co.uk/more/LicenceChanges/rss/article/1174950/Isosorbide-mononitrate-shortage/</link>
<pubDate>Tue, 02 Apr 2013 09:20:00 GMT</pubDate>
<description><![CDATA[The Department of Health has notified healthcare professionals of a supply issue with all standard-release isosorbide mononitrate tablets that is expected to last until May 2013.]]></description>
</item>
<item>
<guid>http://www.mims.co.uk/more/LicenceChanges/rss/article/1174953/Abilify-use-bipolar-disorder-extended/</guid>
<title><![CDATA[Abilify: use in bipolar disorder extended]]></title>
<link>http://www.mims.co.uk/more/LicenceChanges/rss/article/1174953/Abilify-use-bipolar-disorder-extended/</link>
<pubDate>Tue, 02 Apr 2013 09:18:00 GMT</pubDate>
<description><![CDATA[Abilify is now indicated for the treatment of moderate to severe manic episodes in adolescents aged 13 years and older with bipolar I disorder.]]></description>
</item>
<item>
<guid>http://www.mims.co.uk/more/LicenceChanges/rss/article/1172081/Fostair-maintenance-reliever-therapy-asthma/</guid>
<title><![CDATA[Fostair now for maintenance and reliever therapy in asthma]]></title>
<link>http://www.mims.co.uk/more/LicenceChanges/rss/article/1172081/Fostair-maintenance-reliever-therapy-asthma/</link>
<pubDate>Fri, 01 Mar 2013 09:30:00 GMT</pubDate>
<description><![CDATA[Fostair (formoterol/beclometasone) can now be prescribed for patients with asthma who require maintenance and reliever therapy (MART).]]></description>
</item>
<item>
<guid>http://www.mims.co.uk/more/LicenceChanges/rss/article/1172050/Prevenar-13-licensed-5-years/</guid>
<title><![CDATA[Prevenar 13 licensed from 5 years]]></title>
<link>http://www.mims.co.uk/more/LicenceChanges/rss/article/1172050/Prevenar-13-licensed-5-years/</link>
<pubDate>Fri, 01 Mar 2013 09:20:00 GMT</pubDate>
<description><![CDATA[The conjugate pneumococcal vaccine Prevenar 13 is now licensed for use in children aged 5-17 years.]]></description>
</item>
<item>
<guid>http://www.mims.co.uk/more/LicenceChanges/rss/article/1172076/Zytiga-approved-use-chemotherapy/</guid>
<title><![CDATA[Zytiga approved for use before chemotherapy]]></title>
<link>http://www.mims.co.uk/more/LicenceChanges/rss/article/1172076/Zytiga-approved-use-chemotherapy/</link>
<pubDate>Fri, 01 Mar 2013 09:15:00 GMT</pubDate>
<description><![CDATA[The licence for Zytiga (abiraterone) has been extended to include patients with metastatic castration-resistant prostate cancer who are asymptomatic or mildly symptomatic for whom chemotherapy is not yet indicated.]]></description>
</item>
<item>
<guid>http://www.mims.co.uk/more/LicenceChanges/rss/article/1172084/Exjade-first-oral-treatment-non-transfusion-dependent-thalassaemia/</guid>
<title><![CDATA[Exjade: first oral treatment for non-transfusion-dependent thalassaemia]]></title>
<link>http://www.mims.co.uk/more/LicenceChanges/rss/article/1172084/Exjade-first-oral-treatment-non-transfusion-dependent-thalassaemia/</link>
<pubDate>Fri, 01 Mar 2013 09:10:00 GMT</pubDate>
<description><![CDATA[Patients with iron overload in non-transfusion-dependent thalassaemia syndromes (NTDT) can now benefit from the oral chelating agent deferasirox (Exjade).]]></description>
</item>
<item>
<guid>http://www.mims.co.uk/more/LicenceChanges/rss/article/1100962/GSK-vaccine-shortages/</guid>
<title><![CDATA[GSK vaccine shortages]]></title>
<link>http://www.mims.co.uk/more/LicenceChanges/rss/article/1100962/GSK-vaccine-shortages/</link>
<pubDate>Fri, 01 Mar 2013 09:02:00 GMT</pubDate>
<description><![CDATA[GlaxoSmithKline has warned of impending shortages of two of its vaccines.
Owing to a delay in the start-up of a new manufacturing plant, capacity normally reserved for producing typhoid antigen for Typherix and Hepatyrix has been switched to the production of critical childhood vaccines. This situation is expected to last until the end of 2013. Current stocks of Typherix are believed to have been exhausted, but supplies of Hepatyrix are expected to last until the end of the year.
Alternative hepatitis A vaccines are available from GSK, Sanofi Pasteur MSD or Crucell while typhoid vaccines are available from...]]></description>
</item>
<item>
<guid>http://www.mims.co.uk/more/LicenceChanges/rss/article/1165289/Deleted-products-2013/</guid>
<title><![CDATA[Deleted products 2013]]></title>
<link>http://www.mims.co.uk/more/LicenceChanges/rss/article/1165289/Deleted-products-2013/</link>
<pubDate>Mon, 18 Feb 2013 09:00:00 GMT</pubDate>
<description><![CDATA[The following products are no longer available and have been removed from MIMS.]]></description>
</item>
</channel>
</rss>
